These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 24295694

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of Blood-Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase.
    Sato K, Tachikawa M, Watanabe M, Miyauchi E, Uchida Y, Terasaki T.
    Mol Pharm; 2019 Jan 07; 16(1):247-257. PubMed ID: 30495961
    [Abstract] [Full Text] [Related]

  • 25. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
    Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, Janigro D.
    J Cereb Blood Flow Metab; 2008 Feb 07; 28(2):312-28. PubMed ID: 17609686
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
    Kitamura A, Higuchi K, Kurosawa T, Okura T, Kubo Y, Deguchi Y.
    Biol Pharm Bull; 2022 Feb 07; 45(10):1585-1589. PubMed ID: 36184519
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function.
    Griep LM, Wolbers F, de Wagenaar B, ter Braak PM, Weksler BB, Romero IA, Couraud PO, Vermes I, van der Meer AD, van den Berg A.
    Biomed Microdevices; 2013 Feb 07; 15(1):145-50. PubMed ID: 22955726
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of interleukin-6 on drug transporters and permeability in the hCMEC/D3 blood-brain barrier model.
    Simon F, Guyot L, Garcia J, Vilchez G, Bardel C, Chenel M, Tod M, Payen L.
    Fundam Clin Pharmacol; 2021 Apr 07; 35(2):397-409. PubMed ID: 32757312
    [Abstract] [Full Text] [Related]

  • 35. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
    Shimomura K, Okura T, Kato S, Couraud PO, Schermann JM, Terasaki T, Deguchi Y.
    Fluids Barriers CNS; 2013 Jan 26; 10(1):8. PubMed ID: 23351963
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport.
    Yang J, Aschner M.
    Neurotoxicology; 2003 Aug 26; 24(4-5):741-5. PubMed ID: 12900088
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells.
    Lee GS, Pan Y, Scanlon MJ, Porter CJH, Nicolazzo JA.
    J Pharm Sci; 2018 Apr 26; 107(4):1185-1193. PubMed ID: 29247738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.